Key result
Non-sustained ventricular tachycardia (Lown class IV b) was an independent predictor of global mortality (RR 2.6; 95% CI 1.2-6.0) and cardiac mortality in hypertensive patients.
Why the study?
Do arrhythmogenic markers, specifically non-sustained ventricular tachycardia, predict mortality in hypertensive patients?
Population
214 hypertensive patients without symptomatic coronary disease, systolic dysfunction, electrolyte…
Design
Cohort
Follow-up
mean 42.4 +/- 26.8 months
Authors
Loading...
Identifies NSVT as a high-risk marker in uncomplicated hypertension; leaves open whether targeted antiarr.
Cohort (n=214)
Do arrhythmogenic markers, specifically non-sustained ventricular tachycardia, predict mortality in hypertensive patients?
Effect estimate: RR 2.6 (95% CI 1.2-6.0)
Non-sustained ventricular tachycardia is an independent predictor of global and cardiac mortality in hypertensive patients without symptomatic coronary disease or systolic dysfunction.
Galinier et al. (1997) conducted a cohort in Systemic hypertension (n=214). Non-sustained ventricular tachycardia (Lown class IV b) was evaluated on Global mortality (RR 2.6, 95% CI 1.2-6.0). Non-sustained ventricular tachycardia (Lown class IV b) was an independent predictor of global mortality (RR 2.6; 95% CI 1.2-6.0) and cardiac mortality in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: